No article text was recorded for this version.
transcriptomic signature reversal
Version 2 of 2138 papers196 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma
- Blog: Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets
- Blog: Causal reasoning over knowledge graphs leveraging drug-perturbed and disease-specific transcriptomic signatures for drug discovery
- Blog: Integrating population-level and cell-based signatures for drug repositioning
- Blog: AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer
- Blog: Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes
- Blog: Computational Approaches and Pharmacogenomics Data Resources for Drug Repositioning
- Blog: Exploring potential therapeutic agents for lipopolysaccharide-induced septic cardiomyopathy based on transcriptomics using bioinformatics
- Blog: Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes
- Blog: Prediction of repurposed drugs for treating lung injury in COVID-19
- Blog: Bioinformatics driven discovery of small molecule compounds that modulate the FOXM1 and PPARA pathway activities in breast cancer
- Blog: Computational Drug Repurposing for Alzheimer’s Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies
- Blog: sc2MeNetDrug: A computational tool to uncover inter-cell signaling targets and identify relevant drugs based on single cell RNA-seq data
- Blog: Automatic identification of small molecules that promote cell conversion and reprogramming
- Blog: GRAND: A database of gene regulatory network models across human conditions
- Blog: Next-generation precision medicine for suicidality prevention
- Blog: Prim-O-glucosylcimifugin ameliorates aging-impaired endogenous tendon regeneration by rejuvenating senescent tendon stem/progenitor cells
- Blog: Signaling network analysis and drug repurposing for COVID-19 treatment based on transcriptional response of lung host cells
- Blog: Integrative omics data analysis uncovers biomarker genes and potential candidate drugs for G3 medulloblastoma
- Blog: G Protein-Coupled Receptor 40 Agonist LY2922470 Alleviates Ischemic-Stroke-Induced Acute Brain Injury and Functional Alterations in Mice
- Blog: Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2
- Blog: Computational drug repositioning of atorvastatin for ulcerative colitis
- Blog: Clinical connectivity map for drug repurposing: using laboratory results to bridge drugs and diseases
- Blog: Reading the Cell, Designing the Cure: Perturbation-Conditioned Molecular Diffusion for Function-Oriented Drug Design
- Blog: Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways
- Blog: A comprehensive tool for tumor precision medicine with pharmaco-omics data analysis
- Blog: A machine learning-derived immune-related prognostic model identifies PLXNA3 as a functional risk gene in colorectal cancer
- Blog: Causal reasoning over knowledge graphs leveraging drug-perturbed and disease-specific transcriptomic signatures for drug discovery
- Blog: DrugReSC: targeting disease-critical cell subpopulations with single-cell transcriptomic data for drug repurposing in cancer
- Blog: Clinical connectivity map for drug repurposing: using laboratory tests to bridge drugs and diseases
- Blog: GxVAEs: Two Joint VAEs Generate Hit Molecules from Gene Expression Profiles
- Blog: Identification of Repurposable Drugs and Adverse Drug Reactions for Various Courses of COVID-19 Based on Single-Cell RNA Sequencing Data
- Blog: Repurposing the atypical antidepressant trazodone for atherosclerotic cardiovascular disease
- Blog: ASGARD: A Single-cell Guided pipeline to Aid Repurposing of Drugs
- Blog: Drug repositioning for Alzheimer's disease with transfer learning
- Blog: Four Novel Prognostic Genes Related to Prostate Cancer Identified Using Co-expression Structure Network Analysis
- Blog: Time-Course Transcriptome Analysis for Drug Repositioning in Fusobacterium nucleatum-Infected Human Gingival Fibroblasts
- Blog: Identification of candidate target genes of pituitary adenomas based on the DNA microarray
- Blog: Shared Molecular Signatures Across Neurodegenerative Diseases and Herpes Virus Infections Highlights Potential Mechanisms for Maladaptive Innate Immune Responses
- Blog: Opportunities and Challenges in Democratizing Immunology Datasets
- Blog: Proteomic analysis to identification of hypoxia related markers in spinal tuberculosis: a study based on weighted gene co-expression network analysis and machine learning
- Blog: Repositioning linifanib as a potent anti-necroptosis agent for sepsis
- Blog: Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes
- Blog: Identification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data
- Blog: Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in osteosarcoma
- Blog: Drug-Path: a database for drug-induced pathways
- Blog: ASGARD is A Single-cell Guided Pipeline to Aid Repurposing of Drugs
- Blog: A Rational Drug Combination Design to Inhibit Epithelial-Mesenchymal Transition in a Three-Dimensional Microenvironment
- Blog: 'RE: fine drugs': an interactive dashboard to access drug repurposing opportunities
- Blog: Network-based drug repurposing for psychiatric disorders using single-cell genomics
- Blog: Data-driven Biomarker and Drug Discovery using Network-based Approach
- Blog: Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state
- Blog: Repurpose Open Data to Discover Therapeutics for COVID-19 using Deep Learning
- Blog: Integrative discovery of treatments for high-risk neuroblastoma
- Blog: Long Non-coding RNA and mRNA Expression Change in Spinal Dorsal Horn After Exercise in Neuropathic Pain Rats
- Blog: The Key Role and Mechanism of Oxidative Stress in Hypertrophic Cardiomyopathy: A Systematic Exploration Based on Multi-Omics Analysis and Experimental Validation
- Blog: European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation
- Blog: AGTR2, One Possible Novel Key Gene for the Entry of 2019-nCoV into Human Cells
- Blog: TOP2A and CENPF are synergistic master regulators activated in cervical cancer
- Blog: Finding Complex Biological Relationships in Recent PubMed Articles Using Bio-LDA
Showing 60 of 138 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_transcriptomic_signature_reversal_62648c51,
title = {transcriptomic signature reversal},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/transcriptomic-signature-reversal/rdr_62648c510a5941268375f7302891ec24},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_transcriptomic_signature_reversal_62648c51_v2,
title = {transcriptomic signature reversal},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/transcriptomic-signature-reversal/rdr_62648c510a5941268375f7302891ec24/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}